Filing Details
- Accession Number:
- 0000939767-24-000165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-02 20:29:08
- Reporting Period:
- 2024-11-27
- Accepted Time:
- 2024-12-02 20:29:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Biological Products, (No Disgnostic Substances) (2836) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599803 | Jeffrey Hessekiel | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-27 | 129,314 | $18.80 | 644,967 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-27 | 98,908 | $35.93 | 546,059 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-11-29 | 60,000 | $36.67 | 486,059 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-29 | 15,000 | $0.00 | 471,059 | No | 4 | G | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2024-11-27 | 129,314 | $0.00 | 129,314 | $18.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-09-10 | 2025-09-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 999 | Indirect | By 401(k) |
Footnotes
- Includes 207,072 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
- Represents a "net exercise" of an outstanding stock option to purchase 129,314 shares, and pursuant to which the Reporting Person received 30,406 shares, of Common Stock. The Issuer withheld 98,908 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing stock price on November 27, 2024 of $35.93.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $36.36 to $36.93. Reporting Person undertakes to provide Exelixis, Inc., any securityholder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth infootnote 3 to this Form 4.
- On November 29, 2024, the Reporting Person gifted 15,000 shares of Common Stock.
- Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 26, 2024.
- The option, representing the right to purchase a total of 129,314 shares of Common Stock, became fully exercisable on September 10, 2022.
Billionaire Hedge Funds
